Authors:
Nutting, CM
Rowbottom, CG
Cosgrove, VP
Henk, JM
Dearnaley, DP
Robinson, MH
Conway, J
Webb, S
Citation: Cm. Nutting et al., Optimisation of radiotherapy for carcinoma of the parotid gland: a comparison of conventional, three-dimensional conformal, and intensity-modulated techniques, RADIOTH ONC, 60(2), 2001, pp. 163-172
Authors:
McJury, M
Fisher, PM
Pledge, S
Brown, G
Anthony, C
Hatton, MQ
Conway, J
Robinson, MH
Citation: M. Mcjury et al., The impact of virtual simulation in palliative radiotherapy for non-small-cell lung cancer, RADIOTH ONC, 59(3), 2001, pp. 311-318
Citation: Jn. Lund et al., Risks, costs, and compliance limit colorectal adenoma surveillance: lessons from a randomised trial, GUT, 49(1), 2001, pp. 91-96
Authors:
El Helw, LM
Lorigan, PC
Robinson, MH
Coleman, RE
Hancock, BW
Citation: Lm. El Helw et al., VEDex (vincristine, epirubicin dexamethasone): an effective and well tolerated palliative chemotherapy regimen for non-Hodgkin's lymphoma, INT J ONCOL, 16(4), 2000, pp. 777-782
Authors:
Robinson, MH
Rodrigues, VC
Hardcastle, JD
Chamberlain, JO
Mangham, CM
Moss, SM
Citation: Mh. Robinson et al., Faecal occult blood screening for colorectal cancer at Nottingham: detailsof the verification process, J MED SCREE, 7(2), 2000, pp. 97-98
Authors:
Vaarkamp, J
Barber, DC
Conway, J
Robinson, MH
Citation: J. Vaarkamp et al., Automatic image registration of diagnostic and radiotherapy treatment planning CT head images, INT J RAD O, 47(1), 2000, pp. 225-230
Authors:
Dobson, LS
Hancock, H
Bright, N
Robinson, MH
Hancock, BW
Citation: Ls. Dobson et al., Localised non-Hodgkin's lymphoma: The Sheffield Lymphoma Group experience (1970-1995), INT J ONCOL, 13(6), 1998, pp. 1313-1318